ABIGAIL JORDAN: Open Payments
NPI 1336538164 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 25 payments from 14 companies in 2025. Trend: 2023 $429 · 2024 $404 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Galderma Laboratories, L.P. | 4 | $75 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| REVANCE THERAPEUTICS, INC. | 1 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Amgen Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| UCB, Inc. | 1 | $23 |
| Journey Medical Corporation | 1 | $22 |
Products named: SKYRIZI, Zoryve, DAXXIFY, Sotyktu, OTEZLA, NEMLUVIO, DUPIXENT, Bimzelx.
Industry payments across TX — which companies pay providers there.
